ODDB.org: Open Drug Database

Swissmedic Registration	62580	Date of registration	29.04.2013
Company name	Novartis Pharma Schweiz AG	Revision date
		Valid until
Indication		Date of market entry
Index Therapeuticus (BSV)	03.04.30.	Revocation Date
Index Therapeuticus (Swissmedic)	03.04.30.	Information for professionals	IP

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Seebri Breezhaler	50 Mikrogramm, Hartkapseln mit Pulver zur Inhalation	Mikrogramm (Glycopyrronium 50 µg)	R03BB06	CI

2025	©ywesee GmbH